Supernus Pharmaceuticals Inc (SUPN)
Debt-to-assets ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | 0 | 0 | 400,382 | 379,252 | 374,788 | 370,383 | 366,038 | 361,751 | 357,521 | 353,349 | 349,232 |
| Total assets | US$ in thousands | 1,368,070 | 1,342,700 | 1,315,830 | 1,304,090 | 1,277,670 | 1,285,160 | 1,293,100 | 1,791,810 | 1,702,510 | 1,693,130 | 1,694,970 | 1,639,520 | 1,689,150 | 1,555,040 | 1,573,060 | 1,507,440 | 1,504,100 | 1,510,020 | 1,491,020 | 1,189,870 |
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.24 | 0.22 | 0.24 | 0.24 | 0.24 | 0.24 | 0.24 | 0.24 | 0.29 |
December 31, 2024 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $1,368,070K
= 0.00
The debt-to-assets ratio of Supernus Pharmaceuticals Inc has shown a decreasing trend over the analyzed period, starting at 0.29 as of March 31, 2020, and steadily declining to 0.00 by June 30, 2022. This indicates that the company's debt level relative to its total assets has decreased significantly. A debt-to-assets ratio of 0.00 suggests that the company has either reduced its debt to zero or its assets have increased to surpass its existing debt obligations. This could signify improved financial stability and a lower level of financial risk for Supernus Pharmaceuticals Inc. It is essential to continue monitoring the trend of this ratio to assess the company's ongoing financial health and leverage position.
Peer comparison
Dec 31, 2024